Magnetic Resonance Spectroscopy in Clinical Oncology

@article{Golder2004MagneticRS,
  title={Magnetic Resonance Spectroscopy in Clinical Oncology},
  author={W. Golder},
  journal={Oncology Research and Treatment},
  year={2004},
  volume={27},
  pages={304 - 309}
}
  • W. Golder
  • Published 2004
  • Medicine
  • Oncology Research and Treatment
  • The combination of magnetic resonance spectroscopy (MRS) and imaging (MRI) has led to mapping metabolites from normal and neoplastic tissue within the time limits of a routine study. MRSI (magnetic resonance spectroscopy imaging) detects metabolites that contain protons, phosphorus, fluorine, or other nuclei. The uniqueness of the information available in vivo and in a non-invasive manner encouraged radiologists and oncologists to apply MRSI in research and clinical practice. Both 1H- and 31P… CONTINUE READING
    In vivo magnetic resonance spectroscopy in cancer.
    235
    Metabolic brain imaging by magnetic resonance
    2
    Clinical 1h magnetic resonance spectroscopy of brain metastases at 1.5T and 3T
    15

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 38 REFERENCES